Breakthrough in Gene Editing Offers Hope for In-Utero Treatment of Neurodevelopmental Disorders

Researchers have developed a novel method using lipid nanoparticles to deliver gene-editing mRNA to fetal brain cells, potentially preventing conditions like Angelman syndrome before birth.